Trending...
- Wohler releases out-of-band configuration tools for Riedel 2110 SFP's
- New Property Management Directory Launches to Simplify Search for Top Agencies
- Expert tip: Private Jet Engine Maintenance Program - Pros and Cons for Preowned Jet Buyers
Provides the Opportunity to Sell SafeBreak® Vascular in International Markets
FAYETTEVILLE, Ark. - AussieJournal -- Lineus Medical has been granted Certificates of Registration for both EN IS0 13485:2016 and 13485:2016/MDSAP. These certify that the quality management system of Lineus Medical has been registered as conforming to high caliber, international standards. The certified quality management system applies to the design and development, manufacture, and distribution of SafeBreak Vascular.
The certifications were awarded based on passing a rigorous two stage audit conducted by Intertek, an international quality assurance and audit organization. The certificates allow Lineus Medical to enter into international markets with SafeBreak Vascular, the company's flagship product.
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer connector in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
More on Aussie Journal
"Obtaining these certifications is huge for the organization and is a testament to our high-Quality standards," Will Armstrong, COO of Lineus Medical stated. "We can now continue executing our strategic plan and expand into regions such as Japan, Korea, Canada, and Europe."
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally1. Peripheral IVs fail 46% of the time2 before their intended use is complete and cost the US healthcare system over $5B annually1.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
More on Aussie Journal
1Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015; 38(3): 189-203
The certifications were awarded based on passing a rigorous two stage audit conducted by Intertek, an international quality assurance and audit organization. The certificates allow Lineus Medical to enter into international markets with SafeBreak Vascular, the company's flagship product.
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer connector in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
More on Aussie Journal
- Dr. Kelli Ward and Martha Boneta Fain join the advisory board of Legacy PAC , a partner of Veterans for Trump
- Shiny Cleaners Celebrates Years of End-of-Lease Clean Success with Unmatched Customer Satisfaction
- 2023 Employee Handbook Templates Now Available
- Mercy Street to Host the Largest Opening Day Event in the Organization's 20 Year History
- The Nashville International Chopin Piano Competition Announces the Alexei Sultanov Memorial Discovery Prize
"Obtaining these certifications is huge for the organization and is a testament to our high-Quality standards," Will Armstrong, COO of Lineus Medical stated. "We can now continue executing our strategic plan and expand into regions such as Japan, Korea, Canada, and Europe."
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally1. Peripheral IVs fail 46% of the time2 before their intended use is complete and cost the US healthcare system over $5B annually1.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
More on Aussie Journal
- Kobie Voted a Top Workplace USA
- Aquia Inc. Joins the AWS Partner Network and the AWS Public Sector Partner Program
- Perfect Body Laser and Aesthetics ® Offers Tetra CoolPeel Co2 Laser Skin Resurfacing
- Databloom's Blossom Achieves Faster and More Efficient Big Data Analytics
- Orchard Audio's New PecanPi®+ DAC and Streamer Feature AKM's Latest Flagship Chips
1Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015; 38(3): 189-203
Source: Lineus Medical
0 Comments
Latest on Aussie Journal
- Gaming and entertainment company Spinrack Corporation, appoints Jesse Norton as Chief Marketing Officer
- .Store Domains launches Elevate.store – a free-to-use platform for online sellers with deals on business tools
- GP GLOBAL GROUP Secures $18M Sale of Shoppes at 41st Street Retail Plaza in Doral, Florida, with $11.5M CMBS Loan Assumption
- HLN's Immunization Calculation Engine (ICE) is continually updated to support new COVID-19 recommendations
- Rewilding Ireland with Lord Dunsany and IrishTrees
- The Tokyo Rebels Announces the Release of Their Groundbreaking Whitepaper
- Armadillos with Benefits™ - PicPocket-Labs, Inc. details its plans/roadmap at SxSW for combining "location-based NFTs" and loyalty programs
- Microsoft-Backed HRtech Startup ZingHR Invests In SaaS Startup LokiBots
- World Sleep Day, why do we celebrate?
- HGR Alcohol Detox Centers in San Diego Accepts Most Health Insurances
- ShopCHARLI.com Launches Online Store With a Hot New Spring Collection that Doesn't Miss
- Congressman Mark Alford endorsed by Veterans for Trump on his 2024 re-election
- February 2023 Financial Market Review
- Bicycle Sunshade Expands Product Line with Two New Colors
- The Past Reflects A Future - Daniel Imperato 2024 Is Back Again. Which Party?
- Fridge Art Fair New York City May 2023
- Empowering SMEs: Innervation's Supply Chain Finance Solutions for Diverse Business Growth
- AdvisorVault Partners With Compliant Workspace to Help FINRA Firms Achieve 17a-4 Compliance on Microsoft 365
- The New Real Estate "Just Looking" Program Is A Big Hit With Atlanta Area Residents!
- Introducing Music360, the New Social Music Streaming App